Product
Abemaciclib + Fulvestrant
2 clinical trials
5 indications
Indication
HER2-negative Metastatic Breast CancerIndication
Breast CancerIndication
CancerIndication
Breast DiseasesClinical trial
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management. The MINERVA Trial - A Phase IV TrialStatus: Recruiting, Estimated PCD: 2029-04-01
Clinical trial
A Retrospective Real-world Study of Efficacy, Safety, and Economic Assessment of Abemaciclib Tablets Based on Hospital Information System(HIS) in Hormone Recepter Positive(HR+) Breast Cancer PatientsStatus: Not yet recruiting, Estimated PCD: 2024-12-31